
Profound Medical Corp. PROF
$ 6.99
3.56%
Annual report 2023
added 12-27-2025
Profound Medical Corp. Operating Income 2011-2026 | PROF
Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.
FormulaOperating profit = Revenue – Operating expensesFeatures of the metric
- Evaluates business efficiency
Shows how well the company controls its production and administrative costs. - Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies. - Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.
If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.
Annual Operating Income Profound Medical Corp.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | -30.3 M | -18.9 M | -14.9 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -14.9 M | -30.3 M | -21.4 M |
Operating Income of other stocks in the Medical devices industry
| Issuer | Operating Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
EDAP TMS S.A.
EDAP
|
-20.5 M | $ 3.22 | -2.57 % | $ 121 M | ||
|
Align Technology
ALGN
|
608 M | $ 189.61 | -0.56 % | $ 14.2 B | ||
|
Axonics Modulation Technologies
AXNX
|
-64.9 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
-26.9 M | - | 1.37 % | $ 20.5 M | ||
|
Avinger
AVGR
|
-16.6 M | - | -20.74 % | $ 369 K | ||
|
AdaptHealth Corp.
AHCO
|
90.9 M | $ 12.8 | 0.55 % | $ 1.73 B | ||
|
BIOLASE
BIOL
|
-17.9 M | - | -13.19 % | $ 166 K | ||
|
Allied Healthcare Products
AHPI
|
-1.27 M | - | 3.58 % | $ 2.21 M | ||
|
BioSig Technologies
BSGM
|
-71.1 M | - | 37.08 % | $ 85.7 M | ||
|
Conformis
CFMS
|
-46.3 M | - | - | $ 16.4 M | ||
|
Helius Medical Technologies
HSDT
|
-12.4 M | $ 2.16 | 4.85 % | $ 1.31 M | ||
|
Cardiovascular Systems
CSII
|
-35.8 M | - | 0.15 % | $ 844 M | ||
|
Cytosorbents Corporation
CTSO
|
-14.7 M | $ 0.63 | -3.04 % | $ 39.2 M | ||
|
Apollo Endosurgery
APEN
|
-31.4 M | - | - | $ 475 M | ||
|
OrthoPediatrics Corp.
KIDS
|
-39.2 M | $ 16.19 | -0.12 % | $ 380 M | ||
|
ClearPoint Neuro
CLPT
|
-24.2 M | $ 11.78 | 9.58 % | $ 334 M | ||
|
LivaNova PLC
LIVN
|
199 M | $ 64.2 | -1.45 % | $ 3.5 B | ||
|
Dynatronics Corporation
DYNT
|
-2.45 M | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
-112 M | - | - | $ 10.2 M | ||
|
Pulmonx Corporation
LUNG
|
-53.7 M | $ 1.27 | -0.78 % | $ 51.7 M | ||
|
Electromed
ELMD
|
9.66 M | $ 26.39 | 3.57 % | $ 223 M | ||
|
Second Sight Medical Products
EYES
|
-27.6 M | - | -0.97 % | $ 54.4 M | ||
|
GBS
GBS
|
-10.6 M | - | -0.57 % | $ 7.12 M | ||
|
Neovasc
NVCN
|
-31.1 M | - | - | $ 111 M | ||
|
Globus Medical
GMED
|
480 M | $ 94.87 | 0.52 % | $ 12.8 B | ||
|
Orthofix Medical
OFIX
|
-81.4 M | $ 12.35 | 1.65 % | $ 489 M | ||
|
Butterfly Network
BFLY
|
-74.4 M | $ 5.33 | 3.5 % | $ 1.13 B | ||
|
Delcath Systems
DCTH
|
660 K | $ 10.84 | 1.88 % | $ 388 M | ||
|
IRIDEX Corporation
IRIX
|
-2.57 M | $ 1.06 | 0.95 % | $ 18 M | ||
|
Insulet Corporation
PODD
|
474 M | $ 189.56 | -1.38 % | $ 13.3 B | ||
|
CONMED Corporation
CNMD
|
103 M | $ 38.34 | 2.24 % | $ 1.19 B | ||
|
Inspire Medical Systems
INSP
|
51 M | $ 56.31 | -0.07 % | $ 1.65 B | ||
|
Integer Holdings Corporation
ITGR
|
221 M | $ 86.02 | 1.37 % | $ 2.99 B | ||
|
PAVmed
PAVM
|
-21.8 M | $ 9.0 | -1.85 % | $ 6.03 M | ||
|
Invacare Corporation
IVC
|
-80.5 M | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
1.26 B | $ 84.15 | 5.56 % | $ 49.2 B | ||
|
LENSAR
LNSR
|
-24.6 M | $ 5.09 | -3.23 % | $ 60.9 M | ||
|
Sintx Technologies
SINT
|
-10.7 M | $ 2.47 | -1.59 % | $ 6.85 M | ||
|
MiMedx Group
MDXG
|
63.9 M | $ 3.43 | 2.39 % | $ 507 M | ||
|
Stryker Corporation
SYK
|
4.89 B | $ 327.51 | -0.65 % | $ 125 B |